ECSP10010359A - Derivados bicíclicos de carboxamidas aza-bicíclicas, su preparación y su aplicación terapéutica - Google Patents
Derivados bicíclicos de carboxamidas aza-bicíclicas, su preparación y su aplicación terapéuticaInfo
- Publication number
- ECSP10010359A ECSP10010359A EC2010010359A ECSP10010359A ECSP10010359A EC SP10010359 A ECSP10010359 A EC SP10010359A EC 2010010359 A EC2010010359 A EC 2010010359A EC SP10010359 A ECSP10010359 A EC SP10010359A EC SP10010359 A ECSP10010359 A EC SP10010359A
- Authority
- EC
- Ecuador
- Prior art keywords
- bicyclic
- preparation
- group
- carboxamids
- aza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La invención se refiere a los compuestos de fórmula general (I) en la que X1, X2, X3, y X4 representan, independientemente uno del otro, un átomo de nitrógeno o un grupo C-R1; W representa un átomo de oxígeno o de azufre; n es igual a 0, 1, 2 ó 3; Y representa un arilo o un heteroarilo opcionalmente sustituido; A representa el grupo de la fórmula: (II), Z1, Z2, Z3 y Z4 representan, independientemente el uno del otro, un átomo de nitrógeno o un grupo C-R2; Ra y Rb forman junto con los átomos de carbono a los que están unidos, un cicloalquilo parcialmente insaturado, o un arilo; o un heterociclo, o un heteroarilo de 5 a 7 miembros que comprende uno a tres heteroátomos seleccionados de O, S o N; pudiendo estar sustituido este cicloalquilo, este arilo, este heterociclo o este heteroarilo con uno o varios sustituyentes R3; en forma de base o de sal de adición de ácido, así como en forma de hidrato o de solvato. Procedimiento de preparación y aplicación en terapéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800309A FR2926555B1 (fr) | 2008-01-22 | 2008-01-22 | Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010359A true ECSP10010359A (es) | 2010-08-31 |
Family
ID=39832022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010359A ECSP10010359A (es) | 2008-01-22 | 2010-07-20 | Derivados bicíclicos de carboxamidas aza-bicíclicas, su preparación y su aplicación terapéutica |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US8299114B2 (es) |
| EP (1) | EP2235014B1 (es) |
| JP (1) | JP5457370B2 (es) |
| KR (1) | KR20100110876A (es) |
| CN (1) | CN101959877A (es) |
| AR (1) | AR070207A1 (es) |
| AU (1) | AU2009224532B2 (es) |
| BR (1) | BRPI0907628A2 (es) |
| CA (1) | CA2712914C (es) |
| CO (1) | CO6220953A2 (es) |
| CR (1) | CR11574A (es) |
| DO (1) | DOP2010000227A (es) |
| EA (1) | EA201070871A1 (es) |
| EC (1) | ECSP10010359A (es) |
| FR (1) | FR2926555B1 (es) |
| HN (1) | HN2010001460A (es) |
| IL (1) | IL207084A0 (es) |
| MA (1) | MA32088B1 (es) |
| MX (1) | MX2010008042A (es) |
| NI (1) | NI201000123A (es) |
| NZ (1) | NZ586937A (es) |
| PA (1) | PA8813101A1 (es) |
| PE (1) | PE20091321A1 (es) |
| TW (1) | TWI394743B (es) |
| UA (1) | UA102679C2 (es) |
| UY (1) | UY31607A1 (es) |
| WO (1) | WO2009112677A2 (es) |
| ZA (1) | ZA201005205B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2926554B1 (fr) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
| EA037918B1 (ru) | 2011-12-21 | 2021-06-07 | Новира Терапьютикс, Инк. | Противовирусные агенты против гепатита в |
| UA123256C2 (uk) | 2012-08-28 | 2021-03-10 | ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі | Сульфамоїлариламіди та їх застосування як лікарських препаратів для лікування гепатиту b |
| HUE034820T2 (en) | 2013-02-28 | 2018-02-28 | Janssen Sciences Ireland Uc | Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B |
| ES2640063T3 (es) | 2013-04-03 | 2017-10-31 | Janssen Sciences Ireland Uc | Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis B |
| JO3603B1 (ar) | 2013-05-17 | 2020-07-05 | Janssen Sciences Ireland Uc | مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي |
| AU2014267235B2 (en) | 2013-05-17 | 2017-10-05 | Janssen Sciences Ireland Uc | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
| JP6348978B2 (ja) | 2013-07-25 | 2018-06-27 | ヤンセン・サイエンシズ・アイルランド・ユーシー | グリオキサミド置換ピロールアミド誘導体およびｂ型肝炎を処置するための医薬品としてのその使用 |
| ES2655518T3 (es) | 2013-10-23 | 2018-02-20 | Janssen Sciences Ireland Uc | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis B |
| US10392349B2 (en) | 2014-01-16 | 2019-08-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
| US9169212B2 (en) | 2014-01-16 | 2015-10-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
| KR20160128305A (ko) | 2014-02-05 | 2016-11-07 | 노비라 테라퓨틱스, 인코포레이티드 | Hbv 감염의 치료를 위한 병용 요법 |
| CN110483484A (zh) | 2014-02-06 | 2019-11-22 | 爱尔兰詹森科学公司 | 氨磺酰基吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 |
| US9884831B2 (en) | 2015-03-19 | 2018-02-06 | Novira Therapeutics, Inc. | Azocane and azonane derivatives and methods of treating hepatitis B infections |
| US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
| EP3356328A1 (en) | 2015-09-29 | 2018-08-08 | Novira Therapeutics, Inc. | Crystalline forms of a hepatitis b antiviral agent |
| KR20180129943A (ko) | 2016-04-15 | 2018-12-05 | 노비라 테라퓨틱스, 인코포레이티드 | 캡시드 조립 억제제를 포함하는 배합물 및 방법 |
| NZ763766A (en) | 2017-03-20 | 2023-07-28 | Novo Nordisk Healthcare Ag | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators |
| CA3090125A1 (en) | 2018-03-14 | 2019-09-19 | Janssen Sciences Ireland Unlimited Company | Capsid assembly modulator dosing regimen |
| EP3852791B1 (en) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Activating pyruvate kinase r |
| BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
| CN113454077A (zh) | 2019-02-22 | 2021-09-28 | 爱尔兰詹森科学公司 | 用于治疗hbv感染或hbv诱发的疾病的酰胺衍生物 |
| BR112021021454A2 (pt) | 2019-05-06 | 2021-12-21 | Janssen Sciences Ireland Unlimited Co | Derivados de amida úteis no tratamento da infecção por hbv ou doenças induzidas por hbv |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4413696B2 (ja) * | 2004-07-08 | 2010-02-10 | シーケーディ株式会社 | 薬液供給ユニット |
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| JP2006072736A (ja) * | 2004-09-02 | 2006-03-16 | Canon Inc | 情報処理装置及び方法及びプログラム及び記憶媒体 |
| WO2006072735A1 (fr) | 2005-01-05 | 2006-07-13 | Palga International | Procede et installation de fabrication d'un produit alimentaire de forme allongee a l'aide d'un dispositif de restriction et produit alimentaire obtenu |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| DE602005006782D1 (de) * | 2005-06-30 | 2008-06-26 | Agusta Spa | Verbesserte Hubschraubergetriebe |
| FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2897061B1 (fr) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. |
| FR2911604B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2926554B1 (fr) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
-
2008
- 2008-01-22 FR FR0800309A patent/FR2926555B1/fr not_active Expired - Fee Related
-
2009
- 2009-01-20 CA CA2712914A patent/CA2712914C/fr not_active Expired - Fee Related
- 2009-01-20 KR KR1020107018567A patent/KR20100110876A/ko not_active Application Discontinuation
- 2009-01-20 AR ARP090100167A patent/AR070207A1/es not_active Application Discontinuation
- 2009-01-20 MX MX2010008042A patent/MX2010008042A/es active IP Right Grant
- 2009-01-20 JP JP2010543538A patent/JP5457370B2/ja not_active Expired - Fee Related
- 2009-01-20 BR BRPI0907628-0A patent/BRPI0907628A2/pt not_active IP Right Cessation
- 2009-01-20 UA UAA201010235A patent/UA102679C2/ru unknown
- 2009-01-20 EP EP09718719.9A patent/EP2235014B1/fr active Active
- 2009-01-20 CN CN2009801063039A patent/CN101959877A/zh active Pending
- 2009-01-20 WO PCT/FR2009/000051 patent/WO2009112677A2/fr active Application Filing
- 2009-01-20 AU AU2009224532A patent/AU2009224532B2/en not_active Ceased
- 2009-01-20 EA EA201070871A patent/EA201070871A1/ru unknown
- 2009-01-20 NZ NZ586937A patent/NZ586937A/en not_active IP Right Cessation
- 2009-01-20 PE PE2009000065A patent/PE20091321A1/es not_active Application Discontinuation
- 2009-01-21 TW TW098102300A patent/TWI394743B/zh not_active IP Right Cessation
- 2009-01-21 PA PA20098813101A patent/PA8813101A1/es unknown
- 2009-01-22 UY UY031607A patent/UY31607A1/es not_active Application Discontinuation
-
2010
- 2010-07-19 IL IL207084A patent/IL207084A0/en unknown
- 2010-07-20 EC EC2010010359A patent/ECSP10010359A/es unknown
- 2010-07-20 CR CR11574A patent/CR11574A/es not_active Application Discontinuation
- 2010-07-21 US US12/840,661 patent/US8299114B2/en not_active Expired - Fee Related
- 2010-07-21 NI NI201000123A patent/NI201000123A/es unknown
- 2010-07-21 HN HN2010001460A patent/HN2010001460A/es unknown
- 2010-07-21 ZA ZA2010/05205A patent/ZA201005205B/en unknown
- 2010-07-22 CO CO10089474A patent/CO6220953A2/es not_active Application Discontinuation
- 2010-07-22 DO DO2010000227A patent/DOP2010000227A/es unknown
- 2010-08-17 MA MA33096A patent/MA32088B1/fr unknown
-
2012
- 2012-05-08 US US13/466,629 patent/US8604050B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010359A (es) | Derivados bicíclicos de carboxamidas aza-bicíclicas, su preparación y su aplicación terapéutica | |
| NI201000124A (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
| ECSP10010356A (es) | Derivados de carboxamidas n-azabicíclicas, su preparación y su aplicación en terapéutica | |
| ES2624795T3 (es) | Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica | |
| CY1122933T1 (el) | Ενωσεις θειαζολοκαρβοξαμιδιων και πυριδινοκαρβοξαμιδιου χρησιμες ως αναστολεις κινασης ριμ | |
| PE20170303A1 (es) | Derivados de la indolizina como inhibidores de las fosfoinositido-3 quinasas | |
| RU2017105781A (ru) | Индазольные соединения в качестве ингибиторов киназы fgfr, их получение и применение | |
| UY30603A1 (es) | Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica | |
| CO6460743A2 (es) | Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| BR112017019439A2 (pt) | inibidores kv1.3 e sua aplicação médica | |
| NI200800015A (es) | Derivados de n-(heteroaril)-1-heteroarilalquil - 1h - indol - 2 - carboxamidas, su preparación y su aplicación en terapéutica. | |
| AR079077A1 (es) | Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica de enfermedades mediadas por la tirosina quinasa | |
| ECSP11011384A (es) | Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh. | |
| AR066759A1 (es) | Derivados de piperidina-amida | |
| ECSP066810A (es) | Derivados de carbamato de 2h- ó 3h-benzo[e]indazol-1-ilo, su preparación y su aplicación en terapéutica | |
| PH12017501653B1 (en) | Kv1.3 inhibitors and their medical application | |
| AR061519A1 (es) | Derivados de fenilpentadienoilo y composicion farmaceutica | |
| AR078178A1 (es) | Compuestos de benceno-carboxamida como inhibidores de la enzima conver-tidora de tnf | |
| TN2010000333A1 (en) | Bicyclic derivativesof azabicyclic carboxamides, preparation thereof and therapeutic use thereof | |
| UY32370A (es) | Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparación y su aplicación en terapéutica | |
| UY32895A (es) | Derivados acetilénicos de 5-fenilpirazolopiridina, su preparación y su aplicación terapéutica | |
| TH126115B (th) | อนุพันธ์ของคาร์บอกซิลิคแอซิดที่มีวง 2,5-ซับสทิทิวเทดออกซะโซโลพิริมิดีน |